DE2835661C2 - - Google Patents

Info

Publication number
DE2835661C2
DE2835661C2 DE2835661A DE2835661A DE2835661C2 DE 2835661 C2 DE2835661 C2 DE 2835661C2 DE 2835661 A DE2835661 A DE 2835661A DE 2835661 A DE2835661 A DE 2835661A DE 2835661 C2 DE2835661 C2 DE 2835661C2
Authority
DE
Germany
Prior art keywords
group
acid
ethanol
hours
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2835661A
Other languages
German (de)
English (en)
Other versions
DE2835661A1 (de
Inventor
Keith Chadwick Pearl River N.Y. Us Murdock
Frederick Emil Ridgewood N.J. Us Durr
Ralph Grassing Pearl River N.Y. Us Child
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27542240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE2835661(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/903,292 external-priority patent/US4138415A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE2835661A1 publication Critical patent/DE2835661A1/de
Application granted granted Critical
Publication of DE2835661C2 publication Critical patent/DE2835661C2/de
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/62—Alcohols or phenols
    • C08G59/621—Phenols
    • C08G59/623—Aminophenols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/686—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M1/00—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants
    • C10M1/08—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants with additives
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M133/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen
    • C10M133/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen having a carbon chain of less than 30 atoms
    • C10M133/04—Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M133/12—Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19782835661 1977-08-15 1978-08-14 Substituierte diaminoanthrachinone, verfahren zu ihrer herstellung und ihre verwendung Granted DE2835661A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US82487277A 1977-08-15 1977-08-15
US87304178A 1978-01-30 1978-01-30
US87304078A 1978-01-30 1978-01-30
US87317478A 1978-01-30 1978-01-30
US05/903,292 US4138415A (en) 1978-05-05 1978-05-05 1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof

Publications (2)

Publication Number Publication Date
DE2835661A1 DE2835661A1 (de) 1979-03-01
DE2835661C2 true DE2835661C2 (US07534539-20090519-C00280.png) 1991-08-22

Family

ID=27542240

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782835661 Granted DE2835661A1 (de) 1977-08-15 1978-08-14 Substituierte diaminoanthrachinone, verfahren zu ihrer herstellung und ihre verwendung

Country Status (22)

Country Link
JP (1) JPS6463556A (US07534539-20090519-C00280.png)
AR (1) AR225884A1 (US07534539-20090519-C00280.png)
AT (1) AT359484B (US07534539-20090519-C00280.png)
AU (1) AU527103B2 (US07534539-20090519-C00280.png)
BE (1) BE869688A (US07534539-20090519-C00280.png)
CH (1) CH644840A5 (US07534539-20090519-C00280.png)
DD (1) DD139256A5 (US07534539-20090519-C00280.png)
DE (1) DE2835661A1 (US07534539-20090519-C00280.png)
DK (1) DK158836C (US07534539-20090519-C00280.png)
FI (1) FI70882C (US07534539-20090519-C00280.png)
FR (1) FR2400504A1 (US07534539-20090519-C00280.png)
GB (1) GB2004293B (US07534539-20090519-C00280.png)
GR (1) GR74415B (US07534539-20090519-C00280.png)
IE (1) IE47253B1 (US07534539-20090519-C00280.png)
IL (1) IL55218A (US07534539-20090519-C00280.png)
IT (1) IT1107773B (US07534539-20090519-C00280.png)
NL (1) NL188981C (US07534539-20090519-C00280.png)
NO (2) NO148777C (US07534539-20090519-C00280.png)
NZ (1) NZ187989A (US07534539-20090519-C00280.png)
PL (1) PL122586B1 (US07534539-20090519-C00280.png)
PT (1) PT68420A (US07534539-20090519-C00280.png)
SE (1) SE445996B (US07534539-20090519-C00280.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759510B2 (en) 2008-06-11 2014-06-24 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US9045520B2 (en) 2008-12-23 2015-06-02 Gilead Pharmasset Llc Synthesis of purine nucleosides

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275009A (en) * 1979-05-29 1981-06-23 American Cyanamid Company 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones
US4275010A (en) * 1979-10-24 1981-06-23 American Cyanamid Company 5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones
US4296030A (en) * 1980-04-09 1981-10-20 American Cyanamid Company Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
EP0052853A1 (de) * 1980-11-24 1982-06-02 Hoechst Aktiengesellschaft Bis-Aminomethyl-anthrachinon-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
EP0083683A1 (en) * 1981-10-26 1983-07-20 American Cyanamid Company Method of preparing 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and pharmaceutical compositions containing them
EP0154117B1 (en) * 1984-02-27 1989-12-27 American Cyanamid Company Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva
EP0182135A3 (en) * 1984-11-19 1987-08-05 American Cyanamid Company Novel bis-(substituted amino) anthraquinones
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
GB9815910D0 (en) * 1998-07-21 1998-09-23 Btg Int Ltd Synthetic method
DE602004019687D1 (de) * 2003-12-23 2009-04-09 Somanta Ltd Anthraquinonderivate als mittel gegen krebs
SG172359A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside phosphoramidates
BRPI0922508A8 (pt) 2008-12-23 2016-01-19 Pharmasset Inc Análogos de nucleosídeo
PT2752422T (pt) 2010-03-31 2017-11-07 Gilead Pharmasset Llc Síntese estereosseletiva de princípios ativos contendo fósforo
DE102012203981A1 (de) * 2012-03-14 2013-09-19 Henkel Ag & Co. Kgaa Mittel zum Färben und/oder Mattieren von keratinhaltigen Fasern enthaltend neuartige1,4-Diaminoanthrachinonfarbstoffe
GB201214169D0 (en) 2012-08-08 2012-09-19 Biostatus Ltd New compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1422016A (fr) * 1962-10-29 1965-12-24 Oreal Nouveaux colorants anthraquinoniques et leur application à la teinture des cheveux
GB1157506A (en) * 1965-09-10 1969-07-09 Ilford Ltd Anthraquinone Dye Colour Couplers and their use in Colour Photographic Materials
US3700398A (en) * 1970-07-27 1972-10-24 Du Pont Process for dyeing acid-modified nylon fibers
US3646072A (en) * 1970-07-27 1972-02-29 Du Pont Turquoise biscationic anthraquinone dyes
US4051155A (en) * 1975-12-15 1977-09-27 Allied Chemical Corporation Anthraquinone dyes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759510B2 (en) 2008-06-11 2014-06-24 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US9045520B2 (en) 2008-12-23 2015-06-02 Gilead Pharmasset Llc Synthesis of purine nucleosides

Also Published As

Publication number Publication date
FI782481A (fi) 1979-02-16
NO782756L (no) 1979-02-16
GB2004293A (en) 1979-03-28
DK358678A (da) 1979-02-16
NO150482C (no) 1984-10-24
SE445996B (sv) 1986-08-04
NL7808475A (nl) 1979-02-19
FI70882B (fi) 1986-07-18
AR225884A1 (es) 1982-05-14
IT1107773B (it) 1985-11-25
GR74415B (US07534539-20090519-C00280.png) 1984-06-28
CH644840A5 (de) 1984-08-31
NL188981C (nl) 1992-12-01
DK158836C (da) 1991-01-14
IT7850730A0 (it) 1978-08-14
BE869688A (fr) 1979-02-12
DK158836B (da) 1990-07-23
JPH0217534B2 (US07534539-20090519-C00280.png) 1990-04-20
NO820290L (no) 1979-02-16
JPS6463556A (en) 1989-03-09
PL122586B1 (en) 1982-08-31
NO148777B (no) 1983-09-05
AU3877678A (en) 1980-02-14
PT68420A (en) 1978-09-01
FR2400504A1 (fr) 1979-03-16
IE47253B1 (en) 1984-02-08
GB2004293B (en) 1982-06-23
ATA590678A (de) 1980-04-15
FI70882C (fi) 1986-10-27
AU527103B2 (en) 1983-02-17
PL209065A1 (US07534539-20090519-C00280.png) 1980-01-02
SE7807987L (sv) 1979-02-16
DD139256A5 (de) 1979-12-19
FR2400504B1 (US07534539-20090519-C00280.png) 1981-06-26
NZ187989A (en) 1981-07-13
IL55218A (en) 1983-03-31
DE2835661A1 (de) 1979-03-01
AT359484B (de) 1980-11-10
NO148777C (no) 1984-01-25
NO150482B (no) 1984-07-16
IE781636L (en) 1979-02-15

Similar Documents

Publication Publication Date Title
DE2835661C2 (US07534539-20090519-C00280.png)
EP0281902B1 (de) Bis-naphthalimide, ihre Herstellung und Verwendung
DE2434911C2 (de) Phenyläthylamin-Derivate und pharmazeutische Zusammensetzungen
CH635823A5 (de) Verfahren zur herstellung von neuen 1-amidin-3-substituierten-phenylharnstoffen.
DE3789299T2 (de) Verbindungen mit antitumoralen und antibakteriellen Eigenschaften.
DE1470157A1 (de) Verfahren zur Herstellung substituierter Thioxanthensulfonamide und ihrer Saeureanlagerungssalze
DE1770303A1 (de) 1,2,3,4-Tetrahydrocarbazolderivate und Verfahren zu ihrer Herstellung
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3639465A1 (de) Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
DE2840786C2 (US07534539-20090519-C00280.png)
DE2850822C2 (US07534539-20090519-C00280.png)
DE1670386A1 (de) Neue Cyclohexanderivate und Verfahren zu ihrer Herstellung
DE2406065A1 (de) Neue isoindolinderivate, ihre herstellung und die zusammensetzungen, die sie enthalten
DD152334A5 (de) Verfahren zur herstellung von 1-(aminoalkylamino)-5,8-dihydroxy-4-substituierten-anthrachinonen
DE2362979A1 (de) Aminoderivate von pyrazolopyridincarbonsaeuren
CH441291A (de) Verfahren zur Herstellung von organischen Aminen
DE2520171A1 (de) Pyrazolinderivate, ihre n-oxide und salze, verfahren zu ihrer herstellung und arzneimittel
DE69418347T2 (de) Benzoxazinderivate, verfahren diese zu erhalten und ihre verwendung als medikamente
DE2213076A1 (de) Isoxazolo(3,4-b)pyridin-5-carbonsäuren, deren Ester und Salze
AT213872B (de) Verfahren zur Herstellung neuer basischer Phenoläther und ihrer Salze
DE2313625C2 (de) α-(Aminoalkyl)-4-hydroxy-3-(methylsulfonylmethyl)-benzylalkohole, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3015113A1 (de) 4-hydroxy-1,2-benzisothiazol-3(2h)-on-1,1-dioxide, ihre salze, ihre herstellung und verwendung
DE3043446C2 (US07534539-20090519-C00280.png)
DE3043498C2 (US07534539-20090519-C00280.png)
AT235268B (de) Verfahren zur Herstellung sekundärer bzw. tertiärer Amine und deren Additionssalze mit Säuren

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 800

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition